FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208263453> ?p ?o ?g. }

• W3208263453 endingPage "1244" @default.
• W3208263453 startingPage "1244" @default.
• W3208263453 abstract "Malaria is a life-threatening global epidemic disease and has caused more than 400,000 deaths in 2019. To control and prevent malaria, the development of a vaccine is a potential method. An effective malaria vaccine should either combine antigens from all stages of the malaria parasite's life cycle, or epitopes of multiple key antigens due to the complexity of the Plasmodium parasite. Malaria's random constructed antigen-1 (M.RCAg-1) is one of the recombinant vaccines, which was selected from a DNA library containing thousands of diverse multi-epitope chimeric antigen genes. Moreover, besides selecting an antigen, using an adjuvant is another important procedure for most vaccine development procedures. Freund's adjuvant is considered an effective vaccine adjuvant for malaria vaccine, but it cannot be used in clinical settings because of its serious side effects. Traditional adjuvants, such as alum adjuvant, are limited by their unsatisfactory immune effects in malaria vaccines, hence there is an urgent need to develop a novel, safe and efficient adjuvant. In recent years, Pickering emulsions have attracted increasing attention as novel adjuvant. In contrast to classical emulsions, Pickering emulsions are stabilized by solid particles instead of surfactant, having pliability and lateral mobility. In this study, we selected aluminum hydroxide gel (termed as alum) as a stabilizer to prepare alum-stabilized Pickering emulsions (ALPE) as a malaria vaccine adjuvant. In addition, monophosphoryl lipid A (MPLA) as an immunostimulant was incorporated into the Pickering emulsion (ALMPE) to further enhance the immune response. In vitro tests showed that, compared with alum, ALPE and ALMPE showed higher antigen load rates and could be effectively endocytosed by J774a.1 cells. In vivo studies indicated that ALMPE could induce as high antibody titers as Freund's adjuvant. The biocompatibility study also proved ALMPE with excellent biocompatibility. These results suggest that ALMPE is a potential adjuvant for a malaria vaccine." @default.
• W3208263453 created "2021-11-08" @default.
• W3208263453 creator A5008668405 @default.
• W3208263453 creator A5018137098 @default.
• W3208263453 creator A5019359121 @default.
• W3208263453 creator A5025992394 @default.
• W3208263453 creator A5043243831 @default.
• W3208263453 creator A5075161138 @default.
• W3208263453 date "2021-10-26" @default.
• W3208263453 modified "2023-10-16" @default.
• W3208263453 title "Alum Pickering Emulsion as Effective Adjuvant to Improve Malaria Vaccine Efficacy" @default.
• W3208263453 cites W1822718834 @default.
• W3208263453 cites W1965235573 @default.
• W3208263453 cites W1991701295 @default.
• W3208263453 cites W2004220201 @default.
• W3208263453 cites W2054949003 @default.
• W3208263453 cites W2059512105 @default.
• W3208263453 cites W2069370375 @default.
• W3208263453 cites W2081120465 @default.
• W3208263453 cites W2084781504 @default.
• W3208263453 cites W2111033055 @default.
• W3208263453 cites W2134403927 @default.
• W3208263453 cites W2142211209 @default.
• W3208263453 cites W2343187184 @default.
• W3208263453 cites W2743422263 @default.
• W3208263453 cites W2766540226 @default.
• W3208263453 cites W2782472870 @default.
• W3208263453 cites W2883370083 @default.
• W3208263453 cites W2886290895 @default.
• W3208263453 cites W2888637796 @default.
• W3208263453 cites W2901387978 @default.
• W3208263453 cites W2903435434 @default.
• W3208263453 cites W2925017798 @default.
• W3208263453 cites W2947953067 @default.
• W3208263453 cites W2960841028 @default.
• W3208263453 cites W2960894757 @default.
• W3208263453 cites W2991840702 @default.
• W3208263453 cites W2999842278 @default.
• W3208263453 cites W3018823230 @default.
• W3208263453 cites W3033786694 @default.
• W3208263453 cites W3034790204 @default.
• W3208263453 cites W3036446286 @default.
• W3208263453 cites W3038566692 @default.
• W3208263453 cites W3044365302 @default.
• W3208263453 cites W3092842569 @default.
• W3208263453 cites W3130594118 @default.
• W3208263453 cites W3148397116 @default.
• W3208263453 cites W2023157791 @default.
• W3208263453 doi "https://doi.org/10.3390/vaccines9111244" @default.
• W3208263453 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8624716" @default.
• W3208263453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34835175" @default.
• W3208263453 hasPublicationYear "2021" @default.
• W3208263453 type Work @default.
• W3208263453 sameAs 3208263453 @default.
• W3208263453 citedByCount "7" @default.
• W3208263453 countsByYear W32082634532022 @default.
• W3208263453 countsByYear W32082634532023 @default.
• W3208263453 crossrefType "journal-article" @default.
• W3208263453 hasAuthorship W3208263453A5008668405 @default.
• W3208263453 hasAuthorship W3208263453A5018137098 @default.
• W3208263453 hasAuthorship W3208263453A5019359121 @default.
• W3208263453 hasAuthorship W3208263453A5025992394 @default.
• W3208263453 hasAuthorship W3208263453A5043243831 @default.
• W3208263453 hasAuthorship W3208263453A5075161138 @default.
• W3208263453 hasBestOaLocation W32082634531 @default.
• W3208263453 hasConcept C147483822 @default.
• W3208263453 hasConcept C159047783 @default.
• W3208263453 hasConcept C178790620 @default.
• W3208263453 hasConcept C185592680 @default.
• W3208263453 hasConcept C203014093 @default.
• W3208263453 hasConcept C2777863537 @default.
• W3208263453 hasConcept C2778048844 @default.
• W3208263453 hasConcept C2778371730 @default.
• W3208263453 hasConcept C2780924562 @default.
• W3208263453 hasConcept C2781034427 @default.
• W3208263453 hasConcept C71924100 @default.
• W3208263453 hasConcept C8891405 @default.
• W3208263453 hasConceptScore W3208263453C147483822 @default.
• W3208263453 hasConceptScore W3208263453C159047783 @default.
• W3208263453 hasConceptScore W3208263453C178790620 @default.
• W3208263453 hasConceptScore W3208263453C185592680 @default.
• W3208263453 hasConceptScore W3208263453C203014093 @default.
• W3208263453 hasConceptScore W3208263453C2777863537 @default.
• W3208263453 hasConceptScore W3208263453C2778048844 @default.
• W3208263453 hasConceptScore W3208263453C2778371730 @default.
• W3208263453 hasConceptScore W3208263453C2780924562 @default.
• W3208263453 hasConceptScore W3208263453C2781034427 @default.
• W3208263453 hasConceptScore W3208263453C71924100 @default.
• W3208263453 hasConceptScore W3208263453C8891405 @default.
• W3208263453 hasIssue "11" @default.
• W3208263453 hasLocation W32082634531 @default.
• W3208263453 hasLocation W32082634532 @default.
• W3208263453 hasLocation W32082634533 @default.
• W3208263453 hasLocation W32082634534 @default.
• W3208263453 hasOpenAccess W3208263453 @default.
• W3208263453 hasPrimaryLocation W32082634531 @default.
• W3208263453 hasRelatedWork W1906152382 @default.
• W3208263453 hasRelatedWork W1993025569 @default.

• next